{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:11:11Z","timestamp":1764828671556,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009663","name":"University Health Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006126","name":"Hospital for Sick Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ophtha.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T11:21:24Z","timestamp":1555068084000},"page":"1306-1314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma"],"prefix":"10.1016","volume":"126","author":[{"given":"Stephanie N.","family":"Kletke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao Xun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili-Naz","family":"Hazrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda L.","family":"Gallie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh E.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2019.04.003_bib1","series-title":"AJCC Cancer Staging Manual","first-page":"819","article-title":"Retinoblastoma","author":"Mallipatna","year":"2017"},{"key":"10.1016\/j.ophtha.2019.04.003_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.003_bib3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"Munier","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2019.04.003_bib4","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma","volume":"121","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial chemotherapy for retinoblastoma: a systematic review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2019.04.003_bib7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis","volume":"118","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"issue":"Suppl 2","key":"10.1016\/j.ophtha.2019.04.003_bib8","first-page":"S1","article-title":"National Retinoblastoma Strategy Canadian Guidelines for Care: Strat\u00e9gie th\u00e9rapeutique du retinoblastome guide clinique canadien","volume":"44","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.003_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.003_bib10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2019.04.003_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26696","article-title":"Long-term outcomes of group D retinoblastoma eyes during the intravitreal melphalan era","volume":"64","author":"Berry","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archophthalmol.2011.130","article-title":"Periocular topotecan for intraocular retinoblastoma","volume":"129","author":"Mallipatna","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.003_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ophtha.2017.10.015","article-title":"Pars plana vitrectomy and endoresection of refractory intraocular retinoblastoma","volume":"125","author":"Zhao","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.003_bib14","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5858\/133.8.1199","article-title":"Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma","volume":"133","author":"Sastre","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ophtha.2017.01.052","article-title":"Optical coherence tomography-guided decisions in retinoblastoma management","volume":"124","author":"Soliman","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.003_bib16","first-page":"197","article-title":"Genetics and molecular diagnostics in retinoblastoma\u2014an update","volume":"6","author":"Soliman","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"7\u20138","key":"10.1016\/j.ophtha.2019.04.003_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cancergen.2016.06.001","article-title":"Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma","volume":"209","author":"Racher","year":"2016","journal-title":"Cancer Genet"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.0.CO;2-3","article-title":"Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution","volume":"77","author":"Khelfaoui","year":"1996","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ophtha.2019.04.003_bib19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/bjo.77.9.544","article-title":"Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors [see comments]","volume":"77","author":"Shields","year":"1993","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2019.04.003_bib20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8","article-title":"Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors","volume":"73","author":"Shields","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ophtha.2019.04.003_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archopht.120.7.923","article-title":"Postenucleation adjuvant therapy in high-risk retinoblastoma","volume":"120","author":"Honavar","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.04.003_bib22","first-page":"41","article-title":"Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination","volume":"119","author":"Uusitalo","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.003_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/bjo.2003.037044","article-title":"Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?","volume":"88","author":"Chantada","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.04.003_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IIO.0000000000000048","article-title":"Retinoblastoma: evidence for postenucleation adjuvant chemotherapy","volume":"55","author":"Kim","year":"2015","journal-title":"Int Ophthalmol Clin"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archophthalmol.2012.567","article-title":"Outcome of children with retinoblastoma and isolated choroidal invasion","volume":"130","author":"Bosaleh","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2019.04.003_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2018.1501","article-title":"Treatment of nonmetastatic unilateral retinoblastoma in children","volume":"136","author":"Perez","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib27","first-page":"546","article-title":"Management and outcome of unilateral retinoblastoma","volume":"13","author":"Mallipatna","year":"2009","journal-title":"J\u00a0AAPOS"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.003_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bjophthalmol-2017-310624","article-title":"Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye","volume":"102","author":"Fabian","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.04.003_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jfo.2015.03.003","article-title":"Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma","volume":"38","author":"Soliman","year":"2015","journal-title":"Journal Francais D Ophtalmologie"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.003_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/13816810.2014.937543","article-title":"Enucleation refusal for retinoblastoma: a global study","volume":"37","author":"Olteanu","year":"2016","journal-title":"Ophthalmic Genet"},{"issue":"3","key":"10.1016\/j.ophtha.2019.04.003_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/2347-5625.207736","article-title":"Psychosocial factors influencing parental decision to allow or refuse potentially lifesaving enucleation in children with retinoblastoma","volume":"4","author":"Domingo","year":"2017","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"8","key":"10.1016\/j.ophtha.2019.04.003_bib32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ophtha.2009.12.035","article-title":"Implant and prosthesis movement after enucleation: a randomized controlled trial","volume":"117","author":"Shome","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2019.04.003_bib33","first-page":"5","article-title":"Prosthetic fabrication in identical triplets with bilateral retinoblastoma and a single enucleated globe using a myoconjunctival enucleation procedure","volume":"20","author":"Milne","year":"2015","journal-title":"J\u00a0Ophthalmic Prosthet"},{"issue":"7","key":"10.1016\/j.ophtha.2019.04.003_bib34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2010.32.5332","article-title":"Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis","volume":"29","author":"Zhao","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ophtha.2019.04.003_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40942-017-0093-8","article-title":"Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide","volume":"3","author":"Abramson","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.ophtha.2019.04.003_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40942-018-0124-0","article-title":"Re: metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide","volume":"4","author":"Soliman","year":"2018","journal-title":"Int J Retina Vitreous"},{"issue":"10","key":"10.1016\/j.ophtha.2019.04.003_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaophthalmol.2016.2759","article-title":"Intra-arterial chemotherapy for retinoblastoma [reply]","volume":"134","author":"Soliman","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2019.04.003_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/pbc.23239","article-title":"Clinical predictors of high risk histopathology in retinoblastoma","volume":"58","author":"Kashyap","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.ophtha.2019.04.003_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MPH.0b013e3181923cc5","article-title":"Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma","volume":"31","author":"Chantada","year":"2009","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ophtha.2015.01.018","article-title":"Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study","volume":"122","author":"Kaliki","year":"2015","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.04.003_bib41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ophtha.2011.09.037","article-title":"Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study","volume":"119","author":"Chawla","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2019.04.003_bib42","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/IAE.0000000000000547","article-title":"Predictive value of TNM classification, international classification, and Reese-Ellsworth staging of retinoblastoma for the likelihood of high-risk pathologic features","volume":"35","author":"Yousef","year":"2015","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ophtha.2019.04.003_bib43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1120672118781200","article-title":"The predictive value of magnetic resonance imaging of retinoblastoma for the likelihood of high-risk pathologic features","volume":"29","author":"Hiasat","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.04.003_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ophtha.2013.11.021","article-title":"Diagnostic performance of magnetic resonance imaging and computed tomography for advanced retinoblastoma: a systematic review and meta-analysis","volume":"121","author":"de Jong","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.04.003_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bjo.2009.177444","article-title":"A\u00a0clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma","volume":"95","author":"Wilson","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib46","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/IAE.0000000000000861","article-title":"Optic nerve infiltration by retinoblastoma: predictive clinical features and outcome","volume":"36","author":"Kaliki","year":"2016","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ophtha.2019.04.003_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ophtha.2017.01.048","article-title":"High-risk histopathology features in primary and secondary enucleated international intraocular retinoblastoma classification group D eyes","volume":"124","author":"Fabian","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.04.003_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26908","article-title":"Loss of fundus view as an indication for secondary enucleation in retinoblastoma","volume":"65","author":"Berry","year":"2018","journal-title":"Pediatr Blood Cancer"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019300132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019300132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:28Z","timestamp":1758982048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019300132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0161642019300132"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.003","relation":{},"ISSN":["0161-6420"],"issn-type":[{"type":"print","value":"0161-6420"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}